S. R. Waldvogel et al.
orless oil. Rf =0.12 (70% cyclohexane/ethyl acetate); 1H NMR
(400 MHz, CDCl3): d=1.02 (s, 9H), 1.45–1.53 (m, 4H), 1.92–1.98 (m,
2H), 2.64 (t, J=7.1 Hz, 2H), 6.64–6.71 (m, 4H); 13C NMR (100 MHz,
CDCl3): d=24.4, 25.9, 31.1, 40.3, 42.1, 106.8, 120.5, 123.6, 149.0; MS
(ESI+): m/z: 236.1 [M+H]+; HRMS: m/z calcd for C14H22NO2: 236.1651
[M+H+]; found: 236.1645.
6.70–6.76 (m, 4H); 13C NMR (100 MHz, CDCl3): d=17.2, 18.4, 24.4, 32.7,
40.4, 107.2, 119.3, 120.9, 123.0, 148.7; IR n˜ =2247 cmÀ1 (CN); MS (EI,
70 eV): m/z (%): 245.1 (12) [M]+; HRMS: m/z calcd for C15H19NO2:
245.1416 [M]+; found: 245.1415.
General procedure for the oxidative trimerization with MoCl5: Under an
inert atmosphere MoCl5 (1.64 g, 6.0 mmol) was dissolved in CH2Cl2
Compound 5i:
A sealed tube was charged with amine 4 (0.1 g,
(50 mL). The mixture was cooled to 08C and
a solution of ketal
0.425 mmol), 2-bromopyridine (0.67 g, 4.25 mmol), and 2,2,6,6-tetrame-
thylpiperidine (0.08 mL, 0.425 mmol). The mixture was kept at 2218C
(oil bath temperature) for 16 h. The mixture was cooled to RT, dissolved
in CH2Cl2 (20 mL), and transferred into a 50 mL flask. After evaporation
of the solvent, the crude product was purified by column chromatography
(cyclohexane/ethyl acetate, 8:2) to give 5i (0.069 g, 53%) as a colorless
powder. Rf =0.13 (80% cyclohexane/ethyl acetate); m.p. 65–668C;
1H NMR (400 MHz, CDCl3): d=1.03 (s, 9H), 1.65–1.72 (m, 2H), 2.04–
2.07 (m, 2H), 3.23–3.27 (m, 2H), 4.55 (brs, 1H), 6.28–6.30 (m, 1H), 6.51–
6.54 (m, 1H), 6.67–6.74 (m, 4H), 7.33–7.40 (m, 1H), 8.00–8.04 (m, 1H);
13C NMR (100 MHz, CDCl3): d=22.2, 24.5, 31.3, 40.4, 42.2, 106.5, 107.0,
112.6, 120.7, 123.6, 137.5, 147.8, 149.1, 158.6; MS (EI, 70 eV): m/z (%):
312.2 (24) [M]+; HRMS: m/z calcd for C19H24N2O2: 312.1838 [M]+;
found: 312.1834.
(2.0 mmol) in CH2Cl2 (5 mL) was added rapidly. The mixture was stirred
at 08C for the given time (see Table 3). After the conversion the mixture
was partitioned between ethyl acetate (100 mL) and a saturated aqueous
solution of NaHCO3 (100 mL). The aqueous layer was extracted with
ethyl acetate (2ꢃ50 mL) and the combined organic fractions were
washed with H2O (50 mL) and brine (50 mL), dried over anhydrous
MgSO4, and concentrated under reduced pressure. The crude product
was purified by column chromatography on silica by using mixtures of cy-
clohexane and ethyl acetate. The corresponding yields with respect to re-
action time are given in Table 3.
General procedure for the oxidative trimerization with MoCl5/TiCl4 mix-
tures: Under an inert atmosphere MoCl5 (1.64 g, 6.0 mmol) was dissolved
in CH2Cl2 (50 mL), then TiCl4 (0.65 mL, 6.0 mmol) was added. The mix-
ture was cooled to 08C and a solution of ketal (2.0 mmol) in CH2Cl2
(5 mL) was added rapidly. The mixture was stirred at 08C for the given
time (see Table 3). After the conversion the mixture was partitioned be-
Compound I:
A solution of nitrile 5e (0.5 g, 2.2 mmol) in ethanol
(10 mL) was treated with a 10% aqueous solution of NaOH (5 mL). The
reaction mixture was heated at reflux for 17 h before the mixture was di-
luted with H2O (50 mL). The solution was cooled to RT and acidified
with 1m hydrochloric acid (10 mL). The formed solid was filtered off,
rinsed with pure water (3ꢃ50 mL), and subsequently dried under high
tween ethyl acetate (100 mL) and
a saturated aqueous solution of
NaHCO3 (100 mL). The aqueous layer was extracted with ethyl acetate
(2ꢃ50 mL) and the combined organic fractions were washed with H2O
(50 mL) and brine (50 mL), dried over anhydrous MgSO4, and subse-
quently concentrated under reduced pressure. The crude product was pu-
rified by column chromatography on silica by using mixtures of cyclohex-
ane and ethyl acetate. The corresponding yields with respect to time and
reagent mixture are given in Table 3.
vacuum (1ꢃ10À1 mbar) to give acid
I (0.43 g, 80%) as a colorless
powder. Rf =0.11 (80% cyclohexane/ethyl acetate); m.p. 155–1568C;
1H NMR (400 MHz, CDCl3): d=1.05 (s, 9H), 2.30–2.35 (m, 2H), 2.41–
2.46 (m, 2H), 6.66–6.76 (m, 4H); 13C NMR (100 MHz, CDCl3): d=24.4,
27.3, 29.2, 40.3, 107.2, 121.0, 122.8, 148.8, 179.4; MS (EI, 70 eV): m/z
(%): 250.1 (16) [M]+; HRMS: m/z calcd for C14H18O4: 250.1205 [M]+;
found: 250.1211.
Compound 2a (all-syn): Rf =0.10 (80% cyclohexane/ethyl acetate); m.p.
226–2278C; 1H NMR (400 MHz, CDCl3): d=1.11 (s, 27H), 3.09 (s, 6H),
3.44 (s, 9H), 7.70 (s, 6H); 13C NMR (100 MHz, CDCl3): d=24.1, 39.0,
41.0, 51.9, 100.0, 121.4, 124.5, 148.7, 168.9; MS (ESI+): m/z: 767.3
[M+Na]+; elemental analysis calcd (%) for C42H48O12 (744.8233): C
67.74, H 6.50; found: C 67.73, H 6.47.
Compound II: LiAlH4 (0.15 g, 3.6 mmol) was added to an ice-cooled so-
lution of acid I (0.3 g, 1.2 mmol) in diethyl ether (10 mL). The reaction
mixture was stirred for 15 min at 08C and then carefully poured onto ice
water. tBuOMe (30 mL) was added and the mixture was filtered through
a Celite pad. The organic phase was separated and washed several times
with H2O (5ꢃ50 mL) and brine (50 mL), dried over anhydrous MgSO4,
filtered, and evaporated to give II (0.26 g, 93%) as a colorless oil. Rf =
0.21 (80% cyclohexane/ethyl acetate); 1H NMR (400 MHz, CDCl3): d=
1.05 (s, 9H), 1.58–1.67 (m, 2H), 2.02–2.07 (m, 2H), 3.21 (s, 1H), 3.62 (t,
J=6.4 Hz, 2H), 6.64–6.74 (m, 4H); 13C NMR (100 MHz, CDCl3): d=
24.5, 25.5, 30.1, 40.4, 26.8, 107.0, 120.6, 123.7, 149.1; MS (EI, 70 eV): m/z
Compound 2b (anti,anti,syn): Rf =0.24 (80% cyclohexane/ethyl acetate);
m.p. 263–2648C; 1H NMR (400 MHz, CDCl3): d=1.12 (s, 27H), 3.09 (s,
6H), 3.39–3.42 (m, 9H), 7.70 (s, 6H); 13C NMR (100 MHz, CDCl3): d=
24.0, 38.9, 40.9, 51.8, 99.9, 121.4, 124.6, 148.7, 168.9; MS (ESI+): m/z:
767.3 [M+Na]+; HRMS: m/z calcd for C42H48NaO12: 767.3038 [M+Na+];
found: 767.3033.
Compound 6a (all-syn): Rf =0.11 (80% cyclohexane/ethyl acetate);
1H NMR (400 MHz, CDCl3): d=1.11 (d, J=6.8 Hz, 18H), 2.49 (sept, J=
6.8 Hz, 3H), 3.06 (s, 6H), 3.60 (s, 9H), 7.71 (s, 6H); 13C NMR (100 MHz,
CDCl3): d=16.2, 36.0, 40.6, 52.0, 100.8, 119.9, 124.6, 147.9, 168.8; MS
+
+
C
C
(%): 236.1 (14) [M] ; HRMS: m/z calcd for C14H20O3: 236.1412 [M]
;
found 236.1415.
Compound III: A solution of II (0.236 g, 1.0 mmol) in pyridine (10 mL)
was treated with 4-toluenesulfonyl chloride (0.3 g, 1.5 mmol). The reac-
tion mixture was stirred for 8 h at RT, then poured onto ice water. The
formed solid was filtered off, washed with pure water (3ꢃ50 mL), and
desiccated under high vacuum (1ꢃ10À1 mbar) to give tosylate III (0.34 g,
87%) as a colorless powder. Rf =0.54 (80% cyclohexane/ethyl acetate);
m.p. 118–1198C; 1H NMR (400 MHz, CDCl3): d=0.99 (s, 9H), 1.67–1.73
(m, 2H), 1.92–1.96 (m, 2H), 2.44 (s, 3H), 4.01 (t, J=6.2 Hz, 2H), 6.62–
6.74 (m, 4H), 7.32–7.34 (m, 2H), 7.75–7.77 (m, 2H); 13C NMR
(100 MHz, CDCl3): d=21.6, 21.9, 24.4, 30.0, 40.3, 70.6, 107.0, 120.8, 123.1,
127.9, 129.8, 133.1, 144.7, 148.8; MS (EI, 70 eV): m/z (%): 390.1 (8) [M]+;
HRMS: m/z calcd for C21H26O5S: 390.1501 [M]+; found: 390.1502.
(ESI+): m/z: 725.3 [M+Na]+; HRMS: m/z calcd for C39H42NaO12
725.2568 [M+Na+]; found: 725.2564.
:
Compound 7a (anti,anti,syn): Rf =0.18 (80% cyclohexane/ethyl acetate);
1H NMR (400 MHz, CDCl3): d=1.05–1.13 (m, 18H), 2.46–2.54 (m, 3H),
3.01–3.07 (m, 6H), 3.59–3.62 (m, 9H), 7.71 (s, 6H); 13C NMR (100 MHz,
CDCl3): d=16.2, 36.0, 40.6, 51.9, 100.7, 119.9, 124.6, 148.0, 168.7; MS
(ESI+): m/z: 725.3 [M+Na]+; HRMS: m/z calcd for C39H42NaO12
725.2568 [M+Na+]; found: 725.2564.
:
Compound 6b (all-syn): Rf =0.20 (80% cyclohexane/ethyl acetate); m.p.
120–1218C; 1H NMR (400 MHz, CDCl3): d=1.24–1.29 (m, 6H), 1.59–
1.70 (m, 12H), 1.79–1.94 (m, 12H), 2.08–2.15 (m, 3H), 3.05 (s, 6H), 3.60
(s, 9H), 7.69 (s, 6H); 13C NMR (100 MHz, CDCl3): d=25.8, 26.0, 26.9,
40.5, 45.6, 52.0, 100.7, 119.5, 124.6, 147.9, 168.8; MS (ESI+): m/z: 823.4
[M+H]+; HRMS: m/z calcd for C48H55O12: 823.3688 [M+H+]; found:
823.3664.
Compound 5 f: A mixture of tosylate III (0.2 g, 0.51 mmol) and sodium
cyanide (0.04 g, 0.77 mmol) in dimethylsulfoxide (10 mL) was stirred at
808C for 2 h, then poured onto ice water. The formed solid was filtered
off, rinsed with pure water (3ꢃ50 mL), and subsequently desiccated
under high vacuum (1ꢃ10À1 mbar) to give 5 f (0.11 g, 88%) as a colorless
powder. Attention! The filtrate has to be treated with [FeSO4·7H2O] in
acidic media to bind the highly toxic cyanide. Rf =0.37 (85% cyclohex-
ane/ethyl acetate); m.p. 63–648C; 1H NMR (400 MHz, CDCl3): d=1.05
(s, 9H), 1.72–1.79 (m, 2H), 2.09–2.13 (m, 2H), 2.34 (t, J=7.1 Hz, 2H),
Compound 7b (anti,anti,syn): Rf =0.32 (80% cyclohexane/ethyl acetate);
m.p. 126–1278C; 1H NMR (400 MHz, CDCl3): d=1.24–1.29 (m, 6H),
1.63–1.70 (m, 12H), 1.80–1.95 (m, 12H), 2.08–2.16 (m, 3H), 3.05 (s, 6H),
3.58–3.59 (m, 9H), 7.69 (s, 6H); 13C NMR (100 MHz, CDCl3): d=25.8,
25.9, 26.0, 40.5, 45.6, 52.0, 100.7, 119.5, 124.5, 147.9, 168.8; MS (ESI+):
3464
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 3459 – 3466